Ibarakihigashi National Hospital
In research, Ibarakihigashi National Hospital stands highest in Medicine (#17,328 of 17,978 worldwide) and Health Sciences (#19,989 of 20,462 worldwide), over all time.
- World rank, all time
- #42,374 of 42,892
- Rank in Japan
- #2,093 of 2,112
- Research works
- 155 ▲ 6% vs 2013–17
- Citations
- 1k 6.5 per fractional work
- Top-10% rate
- 5.4% record average 16.5%
- Open access
- 28% world 28%
What is Ibarakihigashi National Hospital known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #17,328 of 17,978 | 3.8% | 129 | |
| Health SciencesDomain | #19,989 of 20,462 | 3.7% | 133 |
Each strip is that field’s whole ranked pool, with the notch where Ibarakihigashi National Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 7.7×. Every wedge is a field page.
Who are the top researchers at Ibarakihigashi National Hospital?
Ranked on the composite score, Shimao Fukai, Kenji Hayashihara and Takefumi Saito lead among researchers whose main affiliation is Ibarakihigashi National Hospital.
- 1 Shimao Fukai Japan · #369,002 worldwide 73 citations · 24 works
- 2 Kenji Hayashihara Japan · #759,750 worldwide 18 citations · 24 works
- 3 Takefumi Saito Japan · #1,033,182 worldwide 21 citations · 40 works
- 4 Jun Kanazawa Japan · #1,043,467 worldwide 26 citations · 32 works
- 5 T Aoyagi Japan · #1,489,609 worldwide 4 citations · 19 works
Which keywords describe research at Ibarakihigashi National Hospital?
By fractional works in all years, weighted toward what it does more of than the world: Diagnosis, Treatment, Epidemiology, Chemotherapy, Immune Response, Fibrosis, Drug Resistance and Epithelial-Mesenchymal Transition.
- EGFR Mutations
- Positron Emission Tomography
- Tumor Staging
- Meta-Analysis
- Echocardiography
- Diagnostic Challenges
- Adjuvant Therapy
- Treatment Guidelines
- Nontuberculous Mycobacteria
- Management
- Cystic Fibrosis
- Targeted Therapy
- Tuberculosis
- Vaccine
- Idiopathic Pulmonary Fibrosis
- TGF-ß
- Epithelial-Mesenchymal Transition
- Fibrosis
- Chemotherapy
- Diagnosis
- Epidemiology
- Treatment
- Immune Response
- Drug Resistance
- Interstitial Lung Disease
- Genetic Diversity
- Myofibroblast
- Mycobacterium tuberculosis
- Immunotherapy
- Clinical Trials
- Antibiotic Resistance
- Mycobacterium avium
- Radiotherapy
- Clinical Practice Guidelines
- Abdominal Tuberculosis
- Surgical Management
- Prognostic Factors
- Lung Cancer
- CT Screening
- ALK Inhibitors
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology27▲ 4.4×36 topics
- Diagnosis25▲ 16×15 topics
- Treatment23▲ 12×19 topics
- Chemotherapy11▲ 9.9×11 topics
- Immune Response11▲ 11×8 topics
- Fibrosis10▲ 35×4 topics
- Drug Resistance10▲ 20×3 topics
- Epithelial-Mesenchymal Transition10▲ 73×2 topics
- Interstitial Lung Disease10▲ 114×2 topics
- TGF-ß10▲ 36×2 topics
- Genetic Diversity9▲ 12×2 topics
- Idiopathic Pulmonary Fibrosis9▲ 156×1 topic
- Myofibroblast9▲ 156×1 topic
- Vaccine9▲ 15×2 topics
- Mycobacterium tuberculosis9▲ 91×1 topic
- Tuberculosis9▲ 110×1 topic
- Immunotherapy8▲ 8.0×11 topics
- Targeted Therapy8▲ 24×4 topics
- Clinical Trials8▲ 7.9×4 topics
- Cystic Fibrosis7▲ 58×2 topics
- Antibiotic Resistance7▲ 12×3 topics
- Management7▲ 6.0×11 topics
- Mycobacterium avium7▲ 102×1 topic
- Nontuberculous Mycobacteria7▲ 102×1 topic
- Radiotherapy7▲ 12×6 topics
- Treatment Guidelines7▲ 21×4 topics
- Clinical Practice Guidelines7▲ 7.6×8 topics
- Adjuvant Therapy6▲ 35×2 topics
- Abdominal Tuberculosis6▲ 183×1 topic
- Diagnostic Challenges6▲ 183×1 topic
- Surgical Management6▲ 8.3×8 topics
- Echocardiography6▲ 14×7 topics
- Prognostic Factors6▲ 8.2×11 topics
- Meta-Analysis5▲ 6.4×6 topics
- Lung Cancer5▲ 21×3 topics
- Tumor Staging5▲ 38×2 topics
- CT Screening5▲ 59×1 topic
- Positron Emission Tomography5▲ 59×1 topic
- ALK Inhibitors5▲ 58×1 topic
- EGFR Mutations5▲ 58×1 topic
Which research topics does Ibarakihigashi National Hospital publish most on?
By volume in 2022–2025: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Lung Cancer Diagnosis and Treatment, Tuberculosis Research and Epidemiology and Mycobacterium research and diagnosis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 3 works
- 2 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
- 3 Tuberculosis Research and Epidemiology Infectious Diseases 1 works
- 4 Mycobacterium research and diagnosis Epidemiology 1 works
- 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 6 Lung Cancer Research Studies Oncology 0 works
- 7 Soft tissue tumors and treatment Pathology and Forensic Medicine 0 works
- 8 Dialysis and Renal Disease Management Nephrology 0 works
- 9 Tracheal and airway disorders Pulmonary and Respiratory Medicine 0 works
- 10 Asthma and respiratory diseases Physiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ibarakihigashi National Hospital's research output changed?
Output in 2018–2022 was 6% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Naka
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.